| 臺大學術典藏 |
2022-08-05T07:18:12Z |
Metabolomic and proteomic characterization of sng and pain phenotypes in fibromyalgia
|
Hsu W.-H.; DER-SHENG HAN; Ku W.-C.; Chao Y.-M.; Chen C.-C.; Lin Y.-L. |
| 臺大學術典藏 |
2022-06-27T07:01:50Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
Lee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; CHONG-JEN YU; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-06-27T07:00:05Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:50Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU; CHONG-JEN YU; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2022-06-27T06:59:47Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:43Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:38Z |
Effectiveness of nationwide copd pay-for-performance program on copd exacerbations in Taiwan
|
Cheng S.-L.; Li Y.-R.; Huang N.; CHONG-JEN YU; Wang H.-C.; Lin M.-C.; Chiu K.-C.; Hsu W.-H.; Chen C.-Z.; Sheu C.-C.; Perng D.-W.; Lin S.-H.; Yang T.-M.; Lin C.-B.; Kor C.-T.; Lin C.-H. |
| 臺大學術典藏 |
2022-06-27T06:59:38Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-06-27T06:59:32Z |
Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes
|
Chen Y.-C.; Tsai Y.-H.; Wang C.-C.; Liu S.-F.; Chen T.-W.; Fang W.-F.; Lee C.-P.; Hsu P.-Y.; Chao T.-Y.; Wu C.-C.; Wei Y.-F.; Chang H.-C.; Tsen C.-C.; Chang Y.-P.; Lin M.-C.; CHONG-JEN YU; Wang H.-C.; Chiang C.-H.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Hsiue T.-R.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Chong I.-W.; Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group |
| 臺大學術典藏 |
2022-04-25T06:44:04Z |
XCos: An explainable cosine metric for face verification task
|
Lin Y.-S;Liu Z.-Y;Chen Y.-A;Wang Y.-S;Chang Y.-L;Hsu W.H.; Lin Y.-S; Liu Z.-Y; Chen Y.-A; Wang Y.-S; Chang Y.-L; Hsu W.H.; WINSTON HSU |
| 臺大學術典藏 |
2022-03-10T05:59:46Z |
Anatomical Asymmetry in Goiter: A Demonstration by Three-dimensional Power Doppler Ultrasound
|
Hsieh M.-H.; Chiou S.-C.; Chen C.-C.; Hsu W.-H.; Jeng L.-B.; YI-CHENG CHANG; Lin J.-D. |
| 臺大學術典藏 |
2022-03-04T05:33:28Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-04T05:33:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:39Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
JIH-HSIANG LEE; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:32Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:30Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:46Z |
A training program of a new simplified classification of magnified narrow band imaging for superficial esophageal squamous cell carcinoma
|
Wang W.-L.; Chiu S.Y.-H.; Lee C.-T.; Tseng C.-H.; CHIEN-CHUAN CHEN; Han M.-L.; Chung C.-S.; Hsieh P.-H.; Chang W.-L.; Wu P.-H.; Hsu W.-H.; Yen H.-H.; Wang H.-P.; Chang C.-Y. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 國立成功大學 |
2022 |
Machine learning approaches for screening the risk of obstructive sleep apnea in the Taiwan population based on body profile
|
Tsai, C.-Y.;Liu, W.-T.;Lin, Y.-T.;Lin, S.-Y.;Houghton, R.;Hsu, W.-H.;Wu, D.;Lee, H.-C.;Wu, C.-J.;Li, Li L.Y.J.;Hsu, S.-M.;Lo, C.-C.;Lo, K.;Chen, Y.-R.;Lin, F.-C.;Majumdar, A. |
| 國立成功大學 |
2022 |
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
|
Wang, M.;Yang, J.C.-H.;Mitchell, P.L.;Fang, J.;Camidge, D.R.;Nian, W.;Chiu, Chiu C.-H.;Zhou, J.;Zhao, Y.;Su, W.-C.;Yang, T.-Y.;Zhu, V.W.;Millward, Millward M.;Fan, Y.;Huang, W.-T.;Cheng, Y.;Jiang, L.;Brungs, D.;Bazhenova, L.;Lee, C.K.;Gao, B.;Xu, Y.;Hsu, W.-H.;Zheng, L.;J�nne, P.A. |
| 國立成功大學 |
2022 |
GMI, Ganoderma microsporum protein, suppresses cell mobility and increases temozolomide sensitivity through induction of Slug degradation in glioblastoma multiforme cells
|
Tseng, A.-J.;Tu, Tu T.-H.;Hua, W.-J.;Yeh, H.;Chen, Chen C.-J.;Lin, Z.-H.;Hsu, W.-H.;Chen, Y.-L.;Hsu, C.-C.;Lin, T.-Y. |
| 國立成功大學 |
2022 |
Probiotics-Derived Extracellular Vesicles Protect Oxidative Stress against H2 O2 Induction in Placental Cells
|
Wang, L.-M.;Lee, B.-H.;Hou, C.-Y.;Hsu, W.-H.;Tai, C.-J. |
| 臺大學術典藏 |
2021-11-22T02:27:22Z |
The C-Terminal Sequence and PI motif of the Orchid (Oncidium Gower Ramsey) PISTILLATA (PI) Ortholog Determine its Ability to Bind AP3 Orthologs and Enter the Nucleus to Regulate Downstream Genes Controlling Petal and Stamen Formation
|
Mao, W.-T.; Hsu, H.-F.; Hsu, W.-H.; Li, J.-Y.; Lee, Y.-I.; Yang, C.-H. |
